ConductScience.org, home

Library / Genes

TNFSF13B: TNF superfamily member 13b

1 protein, 653 patents, 7 drugs, 127 trials, 4,669 NIH grants and 10,433 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolTNFSF13BHGNC
NameTNF superfamily member 13bHGNC
NCBI Gene ID10673NCBI Gene
HGNC IDHGNC:11929HGNC
EnsemblENSG00000102524NCBI Gene
AliasesBAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20, TNLG7A, ZTNF4NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q9Y275Tumor necrosis factor ligand superfamily member 13B28512Ensembl, GeneID, HGNCUniProt

Patents 653

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026086743 A2026-05-26184Q9Y275Espacenet
US 12538905 B22026-02-035Q9Y275Espacenet
EP 4650780 A22025-11-199704Q9Y275Espacenet
JP 2025160456 A2025-10-221Q9Y275Espacenet
JP 2025147176 A2025-10-0616778Q9Y275Espacenet
JP 2025529142 A2025-09-045016Q9Y275Espacenet
US 12371689 B22025-07-295016Q9Y275Espacenet
JP 2025517970 A2025-06-129704Q9Y275Espacenet
US 12296007 B22025-05-131Q9Y275Espacenet
JP 2025513582 A2025-04-2425Q9Y275Espacenet

Drugs 7

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ATACICEPTCHEMBL1742986Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL
BELIMUMABCHEMBL1789843Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL
BLISIBIMODCHEMBL2107877Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL
BRIOBACEPTCHEMBL2107844Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL
ROZIBAFUSP ALFACHEMBL4650245Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL
TABALUMABCHEMBL1743075Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL
TIBULIZUMABCHEMBL3990000Tumor necrosis factor ligand superfamily member 13B inhibitorINHIBITORChEMBL

Trials 127

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07340463BELIMUMABPHASE2ClinicalTrials.gov
NCT07225387BELIMUMABPHASE4ClinicalTrials.gov
NCT07020923ATACICEPTPHASE2ClinicalTrials.gov
NCT06993610TIBULIZUMABPHASE2ClinicalTrials.gov
NCT06983028ATACICEPTPHASE2ClinicalTrials.gov
NCT06843239TIBULIZUMABPHASE2ClinicalTrials.gov
NCT06716606BELIMUMABPHASE3ClinicalTrials.gov
NCT06674577ATACICEPTPHASE2ClinicalTrials.gov
NCT06576271BELIMUMABPHASE1ClinicalTrials.gov
NCT06572384BELIMUMABPHASE3ClinicalTrials.gov

NIH grants 4669

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
U54GM104938Oklahoma Shared Clinical and Translational Resources322,025NIH's project files
P30CA016672Cancer Center Support Grant292,025NIH's project files
U19AI110483Regulation of B cell Responses in SLE and Other Autoimmune Diseases202,025NIH's project files
P30CA008748Cancer Center Support Grant192,025NIH's project files
T32AI055428Immune System Development and Regulation192,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award172,025NIH's project files
P01AI125180Plasma Cells in Health and Disease132,025NIH's project files
P30CA072720Cancer Center Support Grant122,025NIH's project files
P30CA016058Cancer Center Support Grant112,025NIH's project files
ZIAAI001222Characterization of the cellular and molecular bases of inborn errors of immunity112,025NIH's project files

Papers 10433

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42819322PubTator, text miningPubMed
42815461PubTator, text miningPubMed
42812913PubTator, text miningPubMed
42810350PubTator, text miningPubMed
42805835PubTator, text miningPubMed
42798829PubTator, text miningPubMed
42790002PubTator, text miningPubMed
42782403PubTator, text miningPubMed
42781881PubTator, text miningPubMed
42781234PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license